We're reading about drug-pricing probe, Novo board shake-up | STAT
The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground for fresh tariffs| STAT
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.| STAT
A feud between the FDA's Vinay Prasad and his staff is threatening the future of the center that regulates vaccines, biological products, and the blood supply| STAT
Bausch Health recently stopped participating in Medicaid and a federal government drug discount program known as 340B| STAT
Bausch Health has exited Medicaid and a federal government drug discount scheme known as 340B, a step that suggests more drugmakers may do the same.| STAT
The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey| STAT
The Trump administration is preparing a new probe into drug-pricing practices among U.S. trading partners, laying the ground for fresh tariffs| STAT
